Recidiva en intestino delgado de tumor de GIST de bajo riesgo: caso clínico y revisión de la literatura

Heine T., Claudio; Medina T., Pedro; Wainstein G., Claudio; Hurtado R., Claudia; Contreras M., Luis; López K., Francisco.
Rev. chil. cir ; 62(1): 72-78, feb. 2010. tab, ilus
Artículo en Español | LILACS | ID: lil-561867

Documentos relacionados

  1. [Long-Term Survival by Low-Dose Imatinib after Recurrence of GIST].
  2. Real-world data on the efficacy and safety of adjuvant chemotherapy in Japanese patients with a high-risk of gastrointestinal stromal tumor recurrence.
  3. Predictive Effectiveness of the Glasgow Prognostic Score for Gastrointestinal Stromal Tumors.
  4. Assessing prognostic factors of long-term survival after surgery for colorectal gastrointestinal stromal tumours.
  5. The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center.
  6. Impact of preoperative tumor rupture timing on gastrointestinal stromal tumor prognosis: a retrospective multicentric cohort study.
  7. [A Case of GIST of Stomach with Peritoneal Dissemination-Long-Term Survival with Imatinib and Surgical Resection].
  8. ASO Author Reflections: The Disease-Free Interval is Associated with Oncologic Outcomes for Patients with Recurrent Gastrointestinal Stromal Tumor.
  9. National Utilization of Imatinib in the Management of Resected Gastrointestinal Stromal Tumors.
  10. Primary EGIST of the greater omentum - a rare presentation.